Healthcare -
Biotechnology - NASDAQ - US
$ 54.54
-0.22 %
$ 3.35 B
Market Cap
-12.62
P/E
RYTM - COST OF REVENUE
Cost of Revenue RYTM - Rhythm Pharmaceuticals, Inc.
9.3 M
LAST VALUE
294.07%
2 YEAR CAGR
83.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR